Pf34

Pf34 (PF3D7_0419700) is a GPI-anchored apical antigen of mature Plasmodium falciparum asexual blood stages that functions as a candidate adhesin during host-cell invasion (PMID:16603573, PMID:20654670). It localizes to the merozoite apex at the rhoptry neck, resides within detergent-resistant (lipid raft-like) microdomains, and is carried forward into newly invaded ring-stage parasites (PMID:17521656). Peptides from its central region bind protease-sensitive receptors on the red blood cell surface and inhibit merozoite invasion in vitro, indicating a role in the adhesive events of RBC entry (PMID:20654670). Pf34 physically interacts with the parasite rhoptry neck protein PfRON6 and with the human hepatocyte receptor FGFR4, and antibodies against Pf34 modestly inhibit sporozoite invasion of primary hepatocytes; the gene is refractory to genetic deletion (PMID:38755636). Beyond these findings, the precise molecular role of Pf34 within the invasion machinery has not been further characterized in the available corpus.

1. 2006 High

   Establishing that Pf34 is post-translationally modified answered whether it is membrane-associated, showing it carries a GPI anchor consistent with a surface-exposed role.

   Evidence Radioactive glucosamine metabolic labeling and mass-spectrometry identification in schizont/merozoite stages

   PMID:16603573

   Open questions at the time

   • Does not localize the protein within the merozoite
   • Does not define a function for the GPI-anchored protein
2. 2007 Medium

   Localization and biochemical fractionation addressed where Pf34 acts, placing it at the rhoptry neck within lipid raft-like microdomains and showing it is transferred into the nascent ring, implicating it in invasion/parasitophorous vacuole formation.

   Evidence Indirect immunofluorescence, stage-specific Western blot, and detergent-resistant microdomain fractionation

   PMID:17521656

   Open questions at the time

   • Functional role inferred from transfer into rings, not tested directly
   • Single lab; no genetic manipulation
3. 2010 Medium

   Receptor-binding and invasion assays tested whether Pf34 engages the host cell, showing central-region peptides bind protease-sensitive RBC receptors and inhibit merozoite invasion, framing Pf34 as an invasion adhesin.

   Evidence Synthetic peptide receptor-ligand binding assays and in vitro RBC invasion inhibition

   PMID:20654670

   Open questions at the time

   • RBC receptor identity not defined
   • Peptide binding may not reflect native full-length protein behavior
4. 2024 Medium

   Interaction screening extended Pf34's adhesin role across life-cycle stages, identifying binding to host FGFR4 and to parasite PfRON6, antibody-inhibitable sporozoite invasion of hepatocytes, and essentiality inferred from failed deletion.

   Evidence Plate-based recombinant protein interaction screen with affinity measurement, monoclonal antibody blockade, sporozoite invasion assay in primary human hepatocytes, and attempted gene knockout

   PMID:38755636

   Open questions at the time

   • FGFR4 interaction shown with recombinant proteins, not in vivo
   • Sporozoite invasion inhibition was modest
   • Refractoriness to deletion not confirmed by conditional approaches

• The native molecular function of Pf34 within the rhoptry/invasion apparatus and the identity of its RBC receptor remain undefined.
• No conditional knockdown to establish essentiality or invasion phenotype
• RBC receptor bound by central-region peptides not molecularly identified
• Structural basis of PfRON6 and FGFR4 interactions unresolved